Consistent with this, introduction of IDH1 mutation or exogenous 2-HG in syngeneic mouse glioma models reduces the levels of CTL-attracting and IFN-gamma-inducible chemokines, including CXCL10 [121]. Here, IDH1 is linked to central nervous system cancer.